ID   GRU-1A
AC   CVCL_N846
SY   GRU-IA
DR   Wikidata; Q54871703
RX   CelloPub=CLPUB00411;
RX   PubMed=7525493;
RX   PubMed=9935182;
CC   Doubling time: 19 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N845 ! GRU-1
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
RX   CelloPub=CLPUB00411;
RA   Petek O.;
RT   "Analysis of expression and mutation of the antimetastatic gene NM23 in
RT   human renal carcinoma cell lines and epithelioid sarcomas.";
RL   Thesis MD (2002); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   PubMed=7525493; DOI=10.1002/ijc.2910590419;
RA   Engers R., Gerharz C.-D., Moll R., Pohl A., Sarbia M., Gabbert H.E.;
RT   "Interclonal heterogeneity in a human epithelioid-sarcoma cell line
RT   (GRU-1).";
RL   Int. J. Cancer 59:548-553(1994).
//
RX   PubMed=9935182; DOI=10.1002/(SICI)1097-0215(19990129)80:3<406::AID-IJC12>3.0.CO;2-L;
RA   Engers R., Gerharz C.-D., Donner A., Mrzyk S., Krause-Paulus R.,
RA   Petek O., Gabbert H.E.;
RT   "In vitro invasiveness of human epithelioid-sarcoma cell lines:
RT   association with cell motility and inverse correlation with the
RT   expression of tissue inhibitor of metalloproteinases.";
RL   Int. J. Cancer 80:406-412(1999).
//